CTSO
Cytosorbents Corp
Price:  
0.86 
USD
Volume:  
110,297.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CTSO EV/EBITDA

-1288.3%
Upside

As of 2024-06-13, the EV/EBITDA ratio of Cytosorbents Corp (CTSO) is -1.65. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CTSO's latest enterprise value is 42.53 mil USD. CTSO's TTM EBITDA according to its financial statements is -25.74 mil USD. Dividing these 2 quantities gives us the above CTSO EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 20.6x - 22.2x 21.8x
Forward P/E multiples 20.4x - 22.5x 21.6x
Fair Price (9.69) - (10.46) (10.22)
Upside -1226.3% - -1316.7% -1288.3%
0.86 USD
Stock Price
(10.22) USD
Fair Price

CTSO EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-06-12 -1.65
2024-06-11 -1.73
2024-06-10 -1.72
2024-06-07 -1.71
2024-06-06 -1.71
2024-06-05 -1.80
2024-06-04 -1.71
2024-06-03 -1.76
2024-05-31 -1.74
2024-05-30 -1.69
2024-05-29 -1.74
2024-05-28 -1.66
2024-05-24 -1.74
2024-05-23 -1.81
2024-05-22 -1.82
2024-05-21 -1.82
2024-05-20 -1.90
2024-05-17 -1.88
2024-05-16 -1.67
2024-05-15 -1.61
2024-05-14 -1.59
2024-05-13 -1.60
2024-05-10 -1.76
2024-05-09 -1.55
2024-05-08 -1.68
2024-05-07 -1.80
2024-05-06 -1.80
2024-05-03 -1.69
2024-05-02 -1.57
2024-05-01 -1.61
2024-04-30 -1.55
2024-04-29 -1.54
2024-04-26 -1.57
2024-04-25 -1.54
2024-04-24 -1.57
2024-04-23 -1.69
2024-04-22 -1.55
2024-04-19 -1.53
2024-04-18 -1.53
2024-04-17 -1.50
2024-04-16 -1.52
2024-04-15 -1.67
2024-04-12 -1.68
2024-04-11 -1.75
2024-04-10 -1.86
2024-04-09 -1.90
2024-04-08 -1.87
2024-04-05 -1.97
2024-04-04 -1.85
2024-04-03 -1.79